Osteo-Spin® technology provides each surgeon an ability to add a multi-level cellular component to each fusion based procedure. Osteo-Spin® patented technology allows for a customizable proprietary blend of activated platelets to be centrifuged at 3600 RPM’s. High RPM cycles allow for creation of a proprietary auto/allograft blend that is first in class for handling characteristics and cellular viability. Create a live cellular graft, point of care without the use of toxic cryoprotectants.
Key Advantages
- Ability to create a Graft – Point of Care
- No Frozen Toxic Cryoprotectants
- Utilizes patients own cells derived from whole autologous blood
- Platelets are activated with proprietary serum
- Surgeon has ability to activate, create and define graft for any void and combine with allo/autograft for unique bone grafting options
Explore our Entire Product Line
Autologous Advanced Biologics
Advanced Synthetics
About Royal
Royal is a pioneering leader in orthobiologic and wound care research and development. Royal’s commitment lies in delivering top-tier, innovative biologic solutions that enhance the healing process and improve patients' quality of life. Royal places patient well-being at the center of its mission, offering exceptional solutions to address a variety of complex needs.
At Royal, our mission is driven by patient-centered care, innovation and excellence, and integrity and compassion. Royal provides a comprehensive array of products tailored to meet the varied needs of the orthobiologic and wound care industry.
As a rapidly expanding force in the industry, Royal is continuously developing and launching new products and solutions that set benchmarks for quality, effectiveness, and patient outcomes. Royal’s commitment to research and innovation keeps it at the forefront of the industry, helping to shape the future of healthcare and improving lives.